Aspira Pathlab & Diagnostics informs about disclosure

16 Mar 2024 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed disclosure, Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from MJay Arvind Bhanushali, Promoters Immediate Relative of the Company for the acquisition of Equity Shares from the market as on March 14, 2024 and March 15, 2024 respectively.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

65.84 0.00 (0.00%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6858.20
Max Healthcare Inst 998.30
Narayana Hrudayalay 1813.15
Aster DM Healthcare 567.20
Global Health 1075.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×